Reviva Pharmaceuticals Stock Forecast - 20 Period Moving Average

RVPH Stock  USD 1.37  0.03  2.24%   
The 20 Period Moving Average forecasted value of Reviva Pharmaceuticals Holdings on the next trading day is expected to be 1.76 with a mean absolute deviation of  0.57  and the sum of the absolute errors of 23.57. Reviva Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Reviva Pharmaceuticals stock prices and determine the direction of Reviva Pharmaceuticals Holdings's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Reviva Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Reviva Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Reviva Pharmaceuticals' systematic risk associated with finding meaningful patterns of Reviva Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Reviva Pharmaceuticals to cross-verify your projections.
  
The current Payables Turnover is estimated to decrease to 0.58. The current Common Stock Shares Outstanding is estimated to decrease to about 15 M. The Reviva Pharmaceuticals' current Net Loss is estimated to increase to about (20.8 M).

Open Interest Against 2024-06-21 Reviva Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Reviva Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Reviva Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Reviva Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Reviva Pharmaceuticals' open interest, investors have to compare it to Reviva Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Reviva Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Reviva. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Reviva Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Reviva Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Reviva Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Reviva Pharmaceuticals Holdings is based on a synthetically constructed Reviva Pharmaceuticalsdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Reviva Pharmaceuticals 20 Period Moving Average Price Forecast For the 3rd of June

Given 90 days horizon, the 20 Period Moving Average forecasted value of Reviva Pharmaceuticals Holdings on the next trading day is expected to be 1.76 with a mean absolute deviation of 0.57, mean absolute percentage error of 0.45, and the sum of the absolute errors of 23.57.
Please note that although there have been many attempts to predict Reviva Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Reviva Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Reviva Pharmaceuticals Stock Forecast Pattern

Backtest Reviva PharmaceuticalsReviva Pharmaceuticals Price PredictionBuy or Sell Advice 

Reviva Pharmaceuticals Forecasted Value

In the context of forecasting Reviva Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Reviva Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 8.35, respectively. We have considered Reviva Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.37
1.76
Expected Value
8.35
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Reviva Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Reviva Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria80.5575
BiasArithmetic mean of the errors 0.47
MADMean absolute deviation0.5748
MAPEMean absolute percentage error0.3059
SAESum of the absolute errors23.5685
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Reviva Pharmaceuticals 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Reviva Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reviva Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reviva Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.227.80
Details
Intrinsic
Valuation
LowRealHigh
0.244.7211.30
Details
3 Analysts
Consensus
LowTargetHigh
13.5014.8316.46
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Reviva Pharmaceuticals. Your research has to be compared to or analyzed against Reviva Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Reviva Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Reviva Pharmaceuticals.

Other Forecasting Options for Reviva Pharmaceuticals

For every potential investor in Reviva, whether a beginner or expert, Reviva Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Reviva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Reviva. Basic forecasting techniques help filter out the noise by identifying Reviva Pharmaceuticals' price trends.

View Reviva Pharmaceuticals Related Equities

 Risk & Return  Correlation

Reviva Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Reviva Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Reviva Pharmaceuticals' current price.

Reviva Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns.

Reviva Pharmaceuticals Risk Indicators

The analysis of Reviva Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reviva Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reviva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Reviva Pharmaceuticals to cross-verify your projections.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Reviva Stock analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.59)
Return On Assets
(1.16)
Return On Equity
(5.56)
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.